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Abstract: As more countries engage in water reuse, either intended or de facto, there is an urgent 
need to more comprehensively evaluate resulting environmental and public health concerns. While 
antibiotic-resistant bacteria (ARB) and antibiotic resistance genes (ARGs) are increasingly coming 
under the spotlight, as emerging contaminants, existing water reuse regulations and guidelines do 
not adequately address these concerns. This perspectives paper seeks to frame the various 
challenges that need to be resolved to identify meaningful and realistic target types and levels of 
antibiotic resistance benchmarks for water reuse. First, there is the need for standardized and 
agreed-upon methodologies to identify and quantify ARB and ARGs. Second, even if methodologies 
are available, identifying which ARB and ARGs to monitor that would best relate to the occurrence 
of disease burden remains unknown. Third, a framework tailored to assessing the risks associated 
with ARB and ARGs during reuse is urgently needed. Fourth, similar to protecting drinking water 
sources, strategies to prevent dissemination of ARB and ARGs via wastewater treatment and reuse 
are required to ensure that appropriate barriers are emplaced. Finally, current wastewater treatment 
technologies could benefit from modification or retrofit to more effectively remove ARB and ARGs 
while also producing a high quality product for water and resource recovery. This perspectives 
paper highlights the need to consider ARB and ARGs when evaluating the overall safety aspects of 
water reuse and ways by which this may be accomplished. 
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1. Introduction: Benefits of Water Reuse 
At least 45 countries worldwide face moderate to severe water scarcity issues [1]. Water stresses 
are further compounded by the need to utilize freshwater for food production. Currently, about 70% 
of the global freshwater supplies are withdrawn for agricultural irrigation [2]. Food production is 
water-thirsty and with the projected increase in global human population from the current 7 billion 
to 9.7 billion in 2050, the amount of water that is to be channeled into food production is expected to 
increase. Intensive mining of groundwater supplies is unsustainable and alternative water resources 
must be considered. 
Worldwide, ~60% of all irrigated croplands fall within 20 km of an urban area, making irrigation 
with municipal wastewater a potential option [3]. Municipal wastewater provides several advantages 
over other alternative sources of irrigation water—It is a reliable water source for farmers, hence 
expanding the growing season and the variety of crops that can be grown [4]. Furthermore, 
depending on the degree of treatment, wastewater generally contains higher nutrient content as 
compared to groundwater. Such nutrients can be assimilated by crops, which can increase crop yields 
and the decrease reliance on chemical fertilizers. The intentional reuse of treated wastewater for 
agricultural irrigation is already practiced throughout the world—about 5000 km2 are irrigated with 
treated wastewater worldwide [1]. On the other hand, the majority of the world’s wastewater is not 
treated and is discharged directly into the environment, contaminating surface waters. An estimated 
2.9 × 107 km2 of croplands (14% of all irrigated croplands) are dependent on surface waters that are 
likely to contain a moderate to high fraction of inadequately treated wastewater [5]. 
The intentional reuse of treated wastewater for other non-potable purposes (e.g., landscape 
irrigation, cooling towers, toilet flushing) also occurs throughout the world; in some cases, 
wastewater is even being treated to permit potable reuse [6]. The majority of the wastewater 
treatment plants (WWTP) worldwide utilize some form of settling and biological treatment, often 
with disinfection as the final step. Activated sludge is one common type of biological treatment, and 
was first developed more than one hundred years ago by Ardern and Lockett [7], with the main 
intention of reducing organics through biodegradation and metabolic processes carried out by dense 
and highly active microbial populations. Public health has improved drastically over the last century, 
with a marked decrease in waterborne disease outbreak, as WWTPs became a widely implemented 
foundation of urban infrastructure. Various benchmarks for assessing WWTP performance and 
resulting water quality have evolved over the years, with most existing regulations requiring utilities 
to assess basic parameters, such as total suspended solids, chemical oxygen demand, biochemical 
oxygen demand, ammonia, nitrate, total phosphorus, and fecal coliforms or Escherichia coli. 
In recent decades, “emerging” contaminants have been identified that may present “new” 
environmental and public health concerns (designated as contaminants of emerging concern, CECs) 
that are not necessarily represented by traditional means of assessing water quality. Substantial effort 
has been placed on improving the activated sludge process and developing new and advanced 
treatment technologies for removing pharmaceuticals and personal care products (PCPPs) [8,9]. 
However, most recent concerns regarding the need for water reuse to provide a safeguard against 
the spread of antibiotic resistance remain to be addressed by the available treatment technologies and 
existing regulations.  
Given that the threat from antimicrobial resistance “has reached alarming levels in many parts 
of the world and that in some settings, few, if any, of the available treatments options remain effective 
for common infections” [10], urgent action is needed in all sectors, including water reuse. Successive 
warnings that antibiotic resistance is one of the most serious human health threats have arisen in 
parallel with the growing evidence of rising levels of antibiotic-resistant bacteria (ARB) and the 
antibiotic resistance genes (ARGs) that they carry in the aquatic environment associated with 
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anthropogenic inputs [10–12]. ARGs enable bacteria to survive in the presence of antibiotics and 
belong to various classes corresponding to their mechanism of action and the class of antibiotic to 
which they encode resistance. A general pattern has been observed, in which ARB and ARGs emerge 
not long after new antibiotics are introduced to the market [13]. Correspondingly, ARGs associated 
with particularly life-threatening infections, encoding resistance to a wide range of antibiotics, have 
been detected in WWTPs or in the environment soon after the first reports of clinical cases [14,15]. 
Phenomena of proliferation, bioaccumulation, and transport have been observed for ARB and ARGs 
in human-impacted environments, bringing to light the potential for exposure to humans and the 
need to delineate possible health risks [11,16,17]. 
The fact that WWTPs receive wastewater that is laden with ARB and ARGs; along with residual 
antibiotics, metals, and other potential selective agents, cannot be ignored, and it is thus critical to 
establish fundamental understanding of the factors that contribute to their proliferation and 
dissipation in the treatment process and to identify effective barriers to their dissemination during 
subsequent reuse. Notably, the highly dense and active microbial populations within a WWTP are 
potentially an ideal setting for selection of ARB and ARGs in treated effluents as well as a site for 
horizontal gene transfer (HGT), or sharing, of ARGs among the bacterial populations. For example, 
bacteriophages are found at extremely high concentrations in secondary sewage effluent, in the range 
of 107 to 108 virus-like particles (VLP) per milliliter [18], where HGT is possible as they mix with and 
infect the dense bacterial populations at a high infection rate [19,20]. The active growing bacteria 
encourage rapid lytic viral replication and large viral burst size [21], conditions that are well-suited 
for generalized gene transfer by transduction, in which bacteriophages mistakenly pick up and 
transfer bacterial DNA fragments, including ARGs [22]. Such concerns arising from ARB and ARGs 
may thus impede subsequent efforts to reuse the treated wastewaters. 
With this context in mind, there is a need to include a more comprehensive assessment of the 
role of wastewater treatment and reuse in the propagation and dissemination of antibiotic resistance. 
This will build up the needed scientific knowledge that is required to inform effective mitigation 
strategies for ARB and ARGs and minimize the potential risks that are associated with water reuse. 
Through this perspectives paper, the aim is to highlight the need to consider ARB and ARGs as 
emerging contaminants in wastewater, to understand the risks that are incurred from ARB and ARGs 
in water reuse contexts, and to lay out various intervention strategies that can be utilized to mitigate 
the risks that are associated with these emerging contaminants. To achieve this aim, the following 
outline topics are discussed in the context of antibiotic resistance and water reuse: 
(i) Current regulations pertaining to microbiological water quality 
(ii) Monitoring and surveillance associated with water reuse 
(iii) Risk assessment of ARB and ARGs 
(iv) Mitigation approaches to safeguard water quality for reuse 
2. Current Regulations Pertaining to Microbiological Water Quality 
Using the European Union (EU) as an example, in spite of the abundance of freshwater in most 
European regions, the Wastewater Directive recommends that treated wastewater should be reused 
whenever appropriate [23]. Although this recommendation was made as early as 1991, a common 
European legislation on water reuse is still lacking to this date. Instead, some countries have 
developed their own recommendations regarding the reuse of treated wastewater. Recommended 
parameters for monitoring the quality of recycled water include microbiological parameters, in 
particular bacteria of enteric origin and indicators of possible fecal contamination (see Table 1 and 
those that are listed by Becerra-Castro et al. [24]). 
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Table 1. Type of parameters and treatment objectives in different sectors of the urban water cycle 
according to European legislation.  
Type of 
Water 
Type of Parameters References 
Wastewater 
Chemical oxygen demand, COD 
[23,25] 
Biochemical oxygen demand, BOD—(can be replaced by total organic 
carbon, TOC, or total oxygen demand, TOD) 
(BOD5 at 20 °C) 
Total suspended solids 
Total phosphorus 
Total nitrogen 
Water for 
reuse 
pH 
See [24] for examples of 
guidelines for Italy, Spain, 
Portugal, France. 
Electrical conductivity, EC 
Sodium absorption rate, SAR 
Total suspended solids, TSS 
Biological oxygen demand, BOD 
Chemical oxygen demand, COD 
Total nitrogen, TN or Nitrate nitrogen, or N–NO3 
Phosphate 
Sulphate 
Faecal coliforms or Escherichia coli 
Nematode eggs 
Surface 
water 
45 priority substances or groups of substances, 21 of which classified as 
priority hazardous substance. 
[26,27] 
Includes plant protection products, biocides, metals and other groups like 
Polyaromatic Hydrocarbons (PAH) that are mainly incineration by-
products and Polybrominated Biphenylethers (PBDE) that are used as 
flame retardants  
Drinking 
water 
A total of 48 microbiological, chemical and indicator parameters must be 
monitored and tested regularly 
[28] 
Microbiological: 
Escherichia coli 
Enterococci 
Pseudomonas aeruginosa 
Clostridium perfringens including spores 
Other heterotrophic bacteria 
Note: Microbial contaminants are in bold. 
Rationale for the assessment of water quality for reuse purposes is largely derived from 
minimum quality requirements established for drinking water, in which the presence of bacteria of 
enteric origin above a certain threshold is considered a criterion of non-compliance (Table 1). In the 
Drinking Water Directive, target thresholds for various water quality parameters have been selected 
based on a combination of scientific information and the precautionary principle. Generally, quality 
requirements are established, assuming that water intended for human consumption must protect 
consumer health on a life-long basis. For example, the World Health Organization (WHO) 
recommends establishing water quality guidelines for different practices using a uniform risk-based 
approach based on Disability-Adjusted Life Years (DALYs). This approach allows for risk to be 
quantified and compared for all types of disease, including acute and chronic, infectious and non-
infectious; where the conversion from illness to DALYs is based on the severity of the disease [29]. A 
commonly used acceptable burden of disease is 10−6 DALYs per person per year (pppy). This risk 
level corresponds to maintaining genotoxins to levels that limit lifetime cancer risk to less than 1 in 
100,000 per person [30]. This risk threshold is also recommended for establishing water quality targets 
for reuse in agriculture. The corresponding tolerable risk for diarrheal pathogens is approximately 1 
in 1000 annual risk per person [31]. While this is a useful framework that could also be applied to 
assessing risk from ARB, it is not straightforward, based on current data, to define equivalent risk 
endpoints. 
Although fecal coliforms are commonly considered in guidelines of reclaimed water intended 
for crop irrigation as indicators of fecal pathogens that cause diarrheal illness, ARB and ARGs are not 
currently considered. There are various barriers to more meaningful and intentional guidelines to 
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protect against the spread of antibiotic resistance via water reuse. In particular, (i) the recognition of 
the importance of ARB and ARGs as contaminants is relatively new; (ii) threshold values have not 
been established and it will be difficult to do so; (iii) mechanisms that influence their selection and 
fate in water and wastewater treatment systems are still poorly understood; (iv) there are logistical 
and economical challenges to putting in place cost-effective and sensitive monitoring and 
surveillance methodologies; and (v) no consensus among the relevant stakeholders on the relative 
risk posed by water reuse compared to other pathways that may contribute to the spread of antibiotic 
resistance.  
Such challenges have motivated discussion centered on defining maximum admissible values 
of ARB and ARGs in treated wastewater [11,32]. Ideally, the maximum admissible value should 
correspond to the minimal risk of transmission and infection to humans. Such a value is still very 
difficult to estimate in the face of limited knowledge about the most prominent sources, paths of 
dissemination, and modes of transmission/colonization/infection in humans [17]. However, as for 
other environmental contaminants, the application of the precautionary principle to the 
dissemination of ARB and ARGs is logical. 
Several questions arise in moving towards proposing maximum admissible values for ARB and 
ARGs. First, even if a given threshold value is proposed and is possible to achieve through 
wastewater treatment, it is not possible to guarantee that ARB and ARGs will not recover and 
proliferate subsequently when the effluent is released to the environment. This is not unlikely, given 
the complex microbial ecology and interplay among bacteria inhabiting sewer lines, water 
distribution system biofilms, river sediments, groundwater, and other receiving environments. Thus, 
monitoring efforts should ideally encompass such receiving environments, with selection of 
threshold targets and values taking into consideration potential for survival, regrowth, and HGT 
between ARB and ARGs with native bacteria residing in such environments. These phenomena are 
still not fully understood and are difficult to predict. 
To resolve this uncertainty, one can propose that a threshold of maximum admissible ARB or 
ARGs in treated wastewater should be “low enough” to reduce the risk of subsequent proliferation 
to very low levels (acceptable risk threshold). However, again there are some obstacles. One is that it 
is difficult to define the “low enough” value; the other is that to propose such a threshold, it would 
be necessary to guarantee that wastewater treatment and disinfection strategies could reach such a 
low value in an affordable manner [33,34]. This may not be realistic, especially for smaller wastewater 
treatment facilities and for low and middle-income regions. A second obstacle is that routine 
monitoring methods to measure ARB and ARGs would need to be able to target such “low levels”, 
meaning that very low quantification limits are required from these methods while maintaining the 
important characteristics of low cost, ease of use, and rapid turnaround time for analysis. 
3. Monitoring and Surveillance of Antibiotic Resistance 
In clinical settings, the current procedure that is established to determine if bacteria isolated from 
an infected host are resistant to antibiotics include cultivation, determination of phenotypic traits, 
serotyping, and antimicrobial susceptibility tests [35]. However, such procedures are often not 
suitable for use in environmental monitoring and surveillance programs given the cost and time 
requirements, nor do they always provide quantitative information. Also, culture-based methods do 
not provide a comprehensive picture of the broader ARG presence in the microbial community 
beyond the cultured target and the potential for HGT unless deeper reconnaissance and sequencing 
of isolates is performed, which is often impractical. However, knowing the abundance of a range of 
ARB along with ARGs they carry in wastewater provides valuable information for assessing the 
potential risks to human health through incorporation of wastewater unit process treatment 
efficiencies with risk models. Similarly, knowing the abundance of ARB and ARGs in the final 
effluent of WWTP allows for one to refine the assessment of treatment effectiveness and to determine 
the associated contaminant load discharged into the environment. 
To address the needs for quantitative measurements, one can utilize various approaches, such 
as (i) enumeration of bacteria on antibiotic-supplemented culture media, (ii) quantitative polymerase 
Water 2018, 10, 244 6 of 21 
 
chain reaction (qPCR) targeting specific ARB or ARG per volume or mass of sample, and (iii) high-
throughput DNA sequencing combined with measurement of total cell counts or total DNA, to allow 
determination of the absolute abundance of cells or genes. 
The recent advancement of metagenomics-based approaches have provided a powerful means 
to give a snapshot of the diversity of ARGs and mobile genetic elements (MGEs) that facilitate HGT 
(e.g., plasmids, integron gene cassettes) in wastewater and environmental samples [36,37]. 
Metagenomics also makes it possible to assess the roles of other microbes besides bacteria, such as 
phages, in propagating resistance in WWTPs, as elucidated in a recent review paper [38].  
To its credit, qPCR allows for the quantitation of gene targets with higher precision and lower 
detection limits when compared with conventional endpoint PCR. For example, up to 104 gene copies 
(GC) of beta-lactamase blaTEM gene, 102 GC of beta-lactamase blaCTX-M gene, and 102 GC of mecA gene 
were found to be present in phages isolated from sewage [39]. Recent review papers have collated 
abundance of ARGs determined by qPCR in various wastewater effluent streams [40,41], while others 
discussed the use of metagenomics to track and perhaps to assign risks that are associated with ARGs 
[42–44]. An extensive elaboration of the various studies has demonstrated the use of these tools, and 
therefore will not be reiterated in this paper. However, depending on the ARB and ARG targets, the 
detection limits provided by qPCR and metagenomics may still not be low enough to allow protection 
of human health from these contaminants. Still, various sample concentration techniques can be 
applied if this truly is a limitation. 
In moving towards selecting targets for environmental monitoring, it is important to recognize 
that all tools have limitations. Molecular methods like qPCR cannot directly differentiate between 
live or dead hosts, nor whether the DNA was extracellular, bacteria-associated, or phage-associated. 
Such distinctions are relevant to fully assessing human and environmental impacts. qPCR is also 
limited in that it is necessary to select one gene at a time, though arrays are now available that can 
target well over 280 genes [45]. Current high-throughput DNA sequencing platforms generate short 
read lengths of up to ~300 bp, which are random in terms of which gene segments are or are not 
captured given the “shot-gun” nature of the approach. Various bioinformatics approaches are under 
development to identify and classify ARGs that are obtained from shot-gun metagenomics 
sequencing, but are limited both by the length and quality of the read as well as the quality of 
available databases for identifying the sequences. Currently, several databases and pipelines are 
available to identify ARGs, MGEs, and other genes of interest [46–48], but there is need for improved 
curation and standardization for comparability purposes. New sequencing platforms, like PacBio, 
that provide long read lengths are now available and provide richer information for gene 
identification and also advance confidence in assembly. Assembly is the process by which 
overlapping portions of reads are identified to produce “contigs” and “scaffolds”, enabling the 
prediction of genomes and moving towards identifying which ARB carry which ARGs.  
There is no doubt that advances in DNA sequencing technologies will play a significant role in 
facilitating future surveillance of ARB and ARGs in the environment. However, sequencing methods 
are not inherently quantitative and provide only relative abundance of genes normalized to total 
reads. Hence, depending on the sequencing coverage, relative abundance obtained from sequencing 
approaches may vary substantially and not be conducive for comparisons across different 
studies/sample sets. If combined with a measure of total cell counts or total DNA (e.g., from qPCR of 
a universal target, flow cytometry, or direct microscopy), relative abundance of genes can be 
converted to total abundance, providing quantitative results. However, this is not yet a common 
approach and may not be accurate enough for risk assessments. Improvements are also needed in 
terms of detection limits, precision, and accuracy, especially if critical ARB or ARG dose thresholds 
are found to be very low or cannot be usefully correlated with genetic markers. Nevertheless, one 
particular advantage of metagenomics data is that it can be assembled in order to identify presence 
of ARBs on an MGE or within a pathogenic host. Reduction in cost can greatly facilitate the application 
of DNA-sequencing based tools to become standard protocols for monitoring ARB and ARGs. 
The next point to consider is which ARB and ARG targets to monitor. Defining which ARB or 
ARG are likely to contribute to infection and disease burden has not been straightforward and is often 
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fraught with uncertainty. Furthermore, ARB are known to be ubiquitously present in nature, even in 
“pristine” environments that have not been exposed to antibiotics [49,50]. Yet, bacterial populations 
were found to possess ARGs, either intrinsically present in their genome or acquired through HGT 
of MGEs. Thus, there is a key need to distinguish ARB and ARGs that are truly representative of risk 
relative to the background. Furthermore, as HGT itself is considered as a risk, monitoring a MGE, 
such as the clinical integron 1 gene cassette [51], which has been proposed as a comprehensive 
indicator of genetic recombination events and antibiotic resistance potential of anthropogenic origin 
[52], would be useful. There is, however, some debate about the utility of this marker. This is because 
most studies rely on detecting only the integrase gene alone without the detection of the 
recombinases and promoter sequence. Hence, the mere detection of integrase gene may not 
necessarily mean that the downstream ARGs contained within the gene cassette would undergo HGT 
(recombination) or be expressed. 
Until suitable methods and targets are agreed upon, surveying a wide suite of ARB, ARGs, and 
MGEs is advisable, enabling the scientific community to move towards eventually identifying which 
targets most meaningfully represent increased disease risks and burdens. It may also be beneficial to 
align a portion of environmental surveillance efforts to match the priorities listed in the WHO’s 
Combat Plan against Antimicrobial Resistance. Specifically, WHO has listed several pathogens as 
priority targets. This list includes carbapenem-resistant Acinetobacter baumannii, Pseudomonas 
aeruginosa, and Enterobacteriaceae (including Klebsiella, E. coli, Serratia and Proteus) [53]. 
4. Advancing Risk Assessment Frameworks for ARB and ARGs in Recycled Water 
Quantitative microbial risk assessment (QMRA) framework provides a useful starting place for 
evaluating the risks that are associated with antibiotic resistance [29,54]. The classical QMRA 
typically consists of: (i) problem formulation or hazard identification; (ii) exposure assessment; (iii) 
dose-response relationships; and (iv) risk characterization and management (Figure 1). However, as 
illustrated here, this framework will require substantial adaptation to understand the risks from ARB 
and ARGs [16,55]. In particular, hazards should include both pathogenic and non-pathogenic ARB 
and ARGs due to the potential for HGT in the environment and within human hosts; the exposure 
assessment should account for HGT of newly acquired ARB in the environment; the dose response 
models should account for impacts of ARGs, history of antibiotic use, and HGT within the host. 
Finally, risk characterization should include impacts of ARB on infection, treatment delays and/or 
failures, and increased risks of both morbidity and mortality.  
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Figure 1. An overview on how the classical quantitative microbial risk assessment framework can be 
applied to understand and assess the risks from antibiotic resistant bacteria and genes. 
4.1. Hazards 
Determining the burdens from antimicrobial resistance exposure requires consideration of the 
following contaminants: 
4.1.1. Bacteria 
Pathogenic ARB are of most direct concern, given that they can lead directly to adverse health 
outcomes in terms of increasing duration and failure rates of medical treatment and increasing risk 
of death [56]. However, non-pathogenic ARB are also a concern as a reservoir with the potential to 
transfer ARGs to non-antibiotic resistant pathogens (see Dose-Response, and Ashbolt et al. [16]). 
Moreover, ARB can be more resistant to water treatment than their non-resistant counterparts, which 
prolongs their survival in the environment. For example, a recent study revealed that an antibiotic-
resistant virulent E. coli strain persisted longer than the less resistant non-virulent E. coli strain upon 
solar radiation, despite both being of the same genus and species [57]. In addition to fecal bacteria, 
which tend to be the focus of monitoring, non-fecal-bacteria are also of concern. Most opportunistic 
pathogenic bacteria are not of fecal origin, but are now the primary source of waterborne disease in 
industrialized countries [58]. 
4.1.2. Genes 
ARGs are subject to mobilization across hosts, via MGEs, which amplifies the risk. They are 
considered as “emerging contaminants” that are independent of the ARB host. ARGs are transported 
through wastewater treatment processes in multiple states, including as functional genes in bacteria, 
on plasmids, encapsulated within phages, and exogenously as extracellular DNA [39,59,60]. HGT 
subsequently can occur via conjugation, transduction, and/or transformation. The rate of HGT by 
each mechanism has not been extensively quantified in the WWTP, where it would be useful to 
identify which mechanisms play the most dominant role. However, inferences can be made from 
other ecosystems. To illustrate, transduction rates that are reported for aquatic environments suggest 
substantial contribution of bacteriophages to the emergence of bacterial strains with new traits and 
potential antibiotic resistant pathogens. The reported frequencies of HGT vary widely; ranging from 
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10−2 to 10−10 transductants per recipient cell, the most common values ranging from 10−5 to 10−9, 
depending on the environmental matrix, the physiological state of the recipient bacteria and the 
bacterium–bacteriophage pair itself [61–63]. The significance of transduction in the environment has 
been presented in several recent reviews [38,64,65] and will not be elaborated upon here. When 
compared to transduction, similar data on conjugation and transformation in environmental systems 
are comparatively limited.  
The fate of ARGs after exiting the WWTP still merits consideration, given their potential to 
remain functional and to be transformed into and replicate within downstream bacterial hosts. 
Notable characteristics of wastewater effluent (namely high nutrient, calcium chloride levels, and 
presence of lytic phages, termed as “phage superspreaders”) have been shown to increase cell 
competency and transformation frequency [66,67]. However, it is unclear whether or not these 
factors, along with other unknown factors, would facilitate exogenous ARGs from wastewater 
effluent to be taken up via transformation and at what rate. Although the risks of possible 
downstream ARG amplification are greatly reduced after wastewater treatment, where designs 
typically achieve 3–4 log removal of bacteria and virus [68,69], the fate and health relevance of 
exogenous DNA remains largely unknown. Clearly more information on the fate, transport, and 
health impacts of ARGs in the scope of water reuse is needed.  
4.2. Exposures 
Exposure assessments integrate data with respect to contaminant concentrations, impact of 
control processes, and specific exposure volumes for each exposure pathway (e.g., consumption of 
food crops, ingestion of water, inhalation) in order to estimate the magnitude and frequency of 
exposures (Figure 1). Data for QMRA is most useful if it is quantitative with estimates of associated 
uncertainty and variability. For antibiotic resistance exposure assessments, quantitative data on 
concentrations in wastewater before and after treatment is needed for ARB, ARGs, and MGEs (see 
Mitigation Strategies). Risks are influenced by state of ARGs (i.e., extracellular, bacteria-associated, 
phage-associated), so data on the state of ARGs is also important. The methods that were used to 
collect the relevant data, including associated challenges and opportunities, are discussed above in 
Monitoring and Surveillance. 
Exposure assessments also require estimates of exposure volumes and intakes. Prior work 
established for enteric and opportunistic pathogens is relevant, especially in the context of both 
potable and non-potable reuse. For example, exposures are estimated for multiple water reuse 
scenarios within the World Health Organization Guidelines for the Safe Use of Wastewater, Excreta 
and Greywater [31] and World Health Organization Quantitative Microbial Risk Assessment: 
Application for Water Safety Management [29]. 
4.3. Dose-Response Relationships 
Existing dose-response relationships used in QMRA are largely based on human and animal 
challenge studies for pathogens without consideration of antibiotic resistance. Antibiotic resistance 
may influence bacterial fitness, i.e., relative advantage for survival and proliferation. Therefore, 
existing dose-response relationships may not adequately reflect infectivity of antibiotic resistant 
strains. Specifically, antibacterial resistance carries a fitness cost that most often reduces growth rate 
and/or virulence [70,71]. However, there are some resistance mechanisms with little-to-no impact on 
growth rate and/or virulence [70], possibly because they are encoded in plasmids that share long 
evolutionary history and hence are highly stable in a particular bacterial host [72]. Occasionally, 
resistance even confers a fitness advantage [70,73]. The impact of ARGs on pathogen infectivity is 
therefore difficult to predict and is based on the combination of the bacterial species and the resistance 
mechanisms, including resistance location (chromosome or plasmid) [70,71]. Dose-response 
relationships also do not account for the impact of recent antibiotic use on pathogen infectivity. A 
recent history of antibiotic use may allow for resistant strains to proliferate and dominate colonization 
sites [74]. New dose-response models are necessary for antibiotic resistant pathogens, especially 
accounting for the increased likelihood of infection following antibiotic treatments. 
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An additional complication with existing dose-response relationships is that risks are modeled 
for exposures to single pathogenic strains. Treated wastewater, however, contains complex microbial 
communities, inclusive of antibiotic-susceptible, antibiotic-resistant, pathogenic, and non-pathogenic 
bacteria. The current dose-response relationships may be insufficient to model risks from exposures 
to mixed communities. Exposures to mixed communities may increase the likelihood of pathogens 
acquiring ARGs or virulence within the human body through, for example, HGT. Not much is known 
about the HGT of ARGs from MGEs or non-pathogenic strains to pathogens inside the human body. 
Studies indicate that ingestion of naked DNA containing ARGs is not a direct concern, as 
transformation into the commensal mammalian gut microbiota is undetectable [75–78]. This may be 
due, in part, to the harsh environment of the mammalian gut and its impact on survival of 
extracellular DNA. Furthermore, human-associated phages in gut microflora and fecal wastes do not 
or rarely carry ARGs [79]. The potential for gene transfer of ARGs to nose, ear, throat, or skin 
microbiota has yet to be studied. Thus, transformation and transduction likely present more risk in 
the environment, rather than in the human gut, in terms of potential for propagation via 
transformation. 
Improved dose-response and other experimental data based on a combination of 
epidemiological data, animal and human challenge studies, and mathematical modeling are 
necessary to accurately characterize risks from exposures to ARB and ARGs during wastewater reuse.  
4.4. Risk Characterization and Management 
Risk characterization refers to estimating the number of people impacted by the identified 
hazard, while management refers to active measures to maintain that level below an acceptable 
burden. In the case of antibiotic resistance, the impact of infections will vary depending on whether 
the outcome of interest is colonization, infection, treatment failure, illness, or death. Adaptation of 
the QMRA framework to antimicrobial resistance will require updating the relationships between 
infection, illness, and DALYs necessary to estimate disease burden. For enteric diseases, this 
conversion is based on a combination of the: (i) probability of illness given infection; (ii) the 
probability of various outcomes given illness (e.g., mild diarrhea, severe diarrhea, or death); and (iii) 
the severity rating of each outcome (representative of the impact of disease on one’s well-being). For 
example, a single rotavirus infection is equivalent to 0.013 DALYs, based on the assumptions that 
rotavirus illness lasts seven days, there is a 97.5% likelihood of mild diarrhea with corresponding 
severity rating of 0.1, a 2.5% likelihood of severe diarrhea with a severity rating of 0.23, and a 0.015% 
likelihood of death [30]. Similar conversion factors for antimicrobial resistant infections do not yet 
exist, but are expected to be higher than those for infections that can be cured by antibiotics. This is 
because antibiotic-resistant infections are usually more serious, last longer, and are more likely to 
lead to death than susceptible infections [56]. Therefore, adaptation of QMRA for antimicrobial 
resistant infections will require expanding conversion factors to account for longer disease duration 
and greater severity. Expanding conversion factors will require consideration of country-level 
differences, as conversion is based on disease surveillance data that are regionally-bounded, and 
therefore may not be representative of the population from different countries [80]. 
Risk characterization for antimicrobial resistant infections will also require reconsidering the 
acceptable disease burden. The WHO acceptable disease burden is defined by DALYs (<10−6 DALYs 
pppy). If resistant infections have a higher infection-to-DALY conversion factor than treatable 
infections, as expected, risk characterization will have to account for the probability that an infection 
is resistant. In contrast, the U.S. EPA defines acceptable disease burden in terms of infections 
(specifically < 10−4 infections pppy). Thus, whether or not an infection is resistant will not influence 
whether or not the tolerable disease burden is exceeded. Generally, the U.S. EPA and WHO disease 
burdens align for enteric diseases (like rotavirus) because the infection-to-DALY conversion factor is 
at or below 0.01 [30]. However, the increased duration and severity of antimicrobial resistant 
infections will shift this relationship.  
Integrating unique considerations with respect to antibiotic resistance as it relates to the four 
core components of the QMRA framework provides a useful conceptual model to understand and 
Water 2018, 10, 244 11 of 21 
 
mitigate risks of antibiotic resistance from water reuse. However, substantial modification and better 
defined knowledge is required to fully utilize this conceptual model for assessing risks of ARB and 
ARGs. 
5. Mitigation Strategies for Antimicrobial Resistance in Recycled Water 
Mitigation and risk assessment ideally go hand in hand, with the latter informing the former 
with respect to target endpoints. However, such target endpoints have yet to be defined as risk 
models tailored to antimicrobial resistance are still in their infancy. Given the gravity of concern for 
the spread of antimicrobial resistance, precautionary action towards adoption and implementation 
of appropriate mitigation strategies is warranted. Here, the holistic perspectives of both the “One 
Health” [81] and “One Water” [82] paradigms, and their convergence, provide useful guidance. 
Ideally, mitigation practices should be in harmony with other environmental and health benefits and 
tailored to local conditions and constraints. In terms of endpoints, mitigation and monitoring should 
complement each other. Given that antibiotic resistance exists in the background, a reasonable 
endpoint target is a level and profile of both ARB, ARGs, and HGT potential that would be 
comparable to the background arising from the use of conventional water source. To exemplify, a 
comparison between treated-wastewater-irrigated and freshwater-irrigated soils found that ARB and 
ARG levels were on the whole identical or sometimes even lower in treated-wastewater irrigated 
soils [83]. Another study irrigated soil microcosms with chlorinated or dechlorinated effluents, and 
did not observe any significant changes in the ARG levels when compared to microcosms that are 
irrigated with deionized water [84]. Still, another study comparing several soils irrigated with treated 
wastewater versus a background soil in urban parks of Victoria, Australia found clear elevation of 
several ARGs in those soils exposed to treated wastewater [85]. Increased monitoring of multiple 
endpoints can provide feedback towards better informing both selection of monitoring targets and 
optimization of risk models. 
Here, we focus on two general aspects of mitigation: Source prevention and treatment 
technologies. 
5.1. Source Prevention as a Barrier to Downstream Proliferation of ARB and ARGs 
Given the existence of antibiotic resistance in the natural background, the concept of source 
control is correspondingly focused on human activities that either directly augment this background 
or result in conditions that stimulate the elevation and mobilization of antibiotic resistance. An 
example of the latter would be dumping of antibiotic-laden waste or heavy metals into waste streams 
or aquatic environments and correspondingly imposing pressure on microbial communities both 
towards selection of strains carrying ARGs [86]. Thus, continued education towards appropriate 
antibiotic use, limited to cases of need in humans and animals remains as a top priority across the 
board for combating antibiotic resistance. 
In the context of water reuse, it is important to consider the upstream influences on the WWTP. 
In particular, several studies have noted that hospital sewage is worthy of special handling 
considerations. Hospital sewage is known to contain higher levels of antibiotics, as well as 
corresponding ARB and ARGs, and markers of hospital-derived ARGs have been ultimately noted 
in water bodies receiving hospital-influenced WWTP effluent [87–89]. Thus, a reasonable 
consideration is the requirement of on-site pre-treatment of hospital sewage before discharging to 
municipal sewers [90,91]. It is important to also recognize that pharmaceutical manufacturing wastes 
are often laden with extremely high levels of antibiotic mixtures and poses a special risk. Especially 
for pharmaceutical plants operating in countries with limited or ineffective environmental regulation 
and high population, there is special concern [92]. However, in certain instances, it is important to 
consider that antibiotics are also taken in domestic households. In a study by Schwartz [93], the 
abundance of ARGs encoding resistance to ampicillin was actually higher in a housing area than in 
corresponding clinical wastewater. Thus, even with focused source control, mitigation within the 
wastewater and recycled treatment processes makes sense. 
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Depending on the intended water reuse application, the target endpoints may differ. For 
example, potable reuse should be held to a higher standard than non-potable reuse. Given the limited 
resources and the need to think holistically regarding the goals of water reuse, more costly treatments 
are less justifiable for the latter. Still, exposures associated with non-potable reuse are often 
overlooked. For example, aerosols can carry opportunistic pathogens, such as Legionella pneumophila 
and Pseudomonas aeruginosa, which can cause pneumonia or colonize the skin and cause infections 
later when the dermal layer is compromised [94]. Thus, it is important in identifying mitigation 
strategies to also manage the safety of the water if it is piped to a different location for reuse. In 
particular, there is also a need to consider preventing regrowth in the distribution system. Currently, 
there is little to no guidance specifically for managing water reuse distribution systems, with 
consideration needed for whether the water is used to irrigate crops, irrigate recreational fields, or 
other activities. Basic questions such as the ideal disinfectants, water storage conditions and water 
age management need to be also addressed. 
Regardless of the intended reuse purpose or local constraints, the need and benefits of basic 
sanitation and hygiene are crystal clear. This is well-illustrated by work documenting the elevation 
of the multi-antibiotic resistance-associated genetic element encoding New Delhi metallo beta-
lactamase NDM-1, in surface waters during pilgrimage to remote sites in India without sanitation 
facilities [95] and in the recovery of NDM-positive E. coli pathogen in untreated wastewater in Saudi 
Arabia during the Hajj pilgrimage month [96]. Thus, an important message is that WWTPs are not to 
blame. Instead, they are a key aspect of the solution. 
5.2. Treatment Technologies to Remove ARB and ARGs 
WWTPs typically employ several steps, including physical, biological and chemical processes. 
A recent surge in research is beginning to provide insight into the relative effects of these treatments 
on ARBs and ARGs. In terms of general bacterial removal, it is estimated that the concentration of 
bacteria in wastewater influent and final effluent are about 109–1012 colony forming unit (CFU)/day 
and 104–106 CFU per day per inhabitant equivalent, respectively [97]. Within a typical WWTP, ARB, 
and ARGs specifically may be removed via several processes, but there is also potential to increase if 
the conditions preferentially select for ARB [68,98] or promote the potential for HGT [99]. 
Initial screening and settling of primary sewage influent produces primary sludge, which may 
be subject to further treatment via sludge digestion and the residuals reused as a soil amendment. 
While the physical processes that are applied to primary sludge will reduce the load of bacteria, 
including ARB, to subsequent stages of treatment, it is important to also consider the effects to 
agroecosystems when residuals are land applied. The effects of residuals application to soil and crops 
varied depending on the region and do not always elevate ARB and ARGs, but the potential of 
residual antibiotics and metals to select and influence horizontal transfer of ARGs in soils [94–96] and 
subsequently to crops is a legitimate concern. Because of such concerns and other unknowns, land 
application has been avoided in some countries. Instead, the incineration of antibiotic-laden sludge 
generated by conventional WWTPs have been opted by some countries to be a better solution in 
reducing antibiotics, ARB, and ARGs than land application [100]. 
Following primary treatment, biological treatment is usually employed as an economical means 
of removing organic matter, nutrients, and other pollutants in the water. Specific biological treatment 
processes are highly variable, from suspended floc growth in the case of standard activated sludge 
treatment to attached biofilm processes, and mixed aerobic and anaerobic stages for biological 
nutrient removal. Following primary treatment, the water still contains some raw-sewage associated 
bacteria and several field studies have been conducted tracking ARB and ARGs through various 
biological treatment processes [68,101,102]. General log removal value (LRV) of bacteria following 
biological treatment is typically around 1-log, while the specific effects on ARB and ARGs are 
relatively more varied, which may be reflective of the nature of the sewage, process performance, 
climatic and unknown factors.  
A general concern is that because biological treatment by nature depends upon highly 
concentrated and active bacteria that are interacting with influent pathogens and ARGs, along with 
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residual metals and antibiotics, WWTPs could be a “hot spot” for the transfer of ARGs [60,103–107]. 
One recent study showed a positive correlation between the solids retention time and numbers of 
Gram-positive ARB [108], demonstrating that nutritional status of the bacteria and the time of 
exposure to antibiotics and other selective agents in the aeration basin can play a role in promoting 
antibiotic resistance. On the other hand, attempts to estimate HGT rates in activated sludge suggest 
that it is not an overly common phenomenon in WWTPs relative to background [109], although more 
work is needed to confirm this observation. In any case, while biological treatment surely will and 
should remain as an important pillar to wastewater treatment, it is doubtful that it can be relied upon 
fully for the reduction of ARB and ARGs. Therefore, other downstream barriers should be explored, 
especially when intending the water for reuse. 
Tertiary treatments of WWTP effluents for the purpose of non-potable reuse are usually 
comprised of filtration (typically granular media filtration or membrane filtration, such as micro- or 
ultra-filtration), and disinfection. Chlorination is one of the most used disinfection systems to 
decrease the total amount of bacteria in wastewater effluents. However, questions remain with 
respect to the ability of impaired bacteria to survive and regrow, especially in water reuse distribution 
systems [94]. According to the WaterVal chlorine disinfection validation protocol [110], based on the 
U.S. EPA disinfection profiling and benchmarking guidance manual [111], a treatment plant could 
validate for a 2-log LRV of bacteria by using a typical CT (i.e., concentration of disinfectant multiplied 
by contact time) value of 5 mg·min/L at 20 °C, pH 7–7.5 and turbidity ≤5 NTU. However, several 
studies showed an increase of the proportion of ARB over a typical dose range (0.5–5 mg/L) and CT 
value used in WWTPs [112–115]. In contrast, higher dose and CT values (i.e., lethal doses) result in 
extensive fragmentation and precipitation of DNA-protein complexes [116], which may signify a 
good way to reduce ARB and ARGs. At extremely high doses (e.g., 80 mg Cl·min/L), Guo and 
coworkers demonstrated that ARG transfer was greatly suppressed [112], but such a high dose is not 
practical and could have other consequences. Besides the formation of toxic, carcinogenic disinfection 
byproducts (DBPs), which would significantly increase the chemical risks that are associated with 
water reuse, work has also shown that the DBPs produced by chlorination could also select for ARGs 
[99]. Thus, the ultimate impact of chlorine on ARB and ARGs is still debatable and it is not wise to 
rely on chlorination as the sole barrier. 
Ultraviolet (UV) disinfection is an alternative to chlorine since it does not produce toxic DBPs, 
prompting many WWTPs to switch from chlorine to UV. According to the U.S. EPA ultraviolet 
disinfection guidance manual [117], the required dose to achieve 2-log inactivation for 
Cryptosporidium, Giardia and virus is 5.8, 5.2 and 100 mJ/cm2, respectively. In addition, the guidelines 
recommend that the highest UV dose would be 186 mJ/cm2 to achieve 4-log inactivation of viruses. 
This is generally thought to be sufficient to kill most co-occurring bacteria, since viruses are generally 
harder to inactivate than bacteria. However, an earlier study has found that, while this recommended 
dose would be sufficient to inactivate ARB (10 to 20 mJ/cm2 to achieve 5-log inactivation), it would 
result in varying efficacies in removing different types of ARGs. For instance, tetA and ampC genes 
(which confer resistance against tetracycline and ampicillin, respectively) would only be reduced by 
1 to 2-log, while mecA and vanA (which confer resistance against methicillin and vancomycin, 
respectively) would be reduced by 3 to 4-log [34]. This large variation in inactivation efficiencies 
suggests a selective enrichment of certain types of ARGs that may be more resistant against UV 
treatment in the final treated water. Prior work demonstrated that the nature of the DNA sequence 
(e.g., number of adjacent thymine bases) dictates the susceptibility of ARGs to UV disinfection [34]. 
Collectively, these findings seem to suggest that tertiary treatment processes demonstrate limited 
effectiveness at removing ARB and ARGs. However, it remains unknown if the corresponding risks 
levels arising from the remnant ARB and ARGs would exceed that of the acceptable level for non-
potable reuse. 
Beyond tertiary treatment, advanced treatment, including ozone, advanced oxidation processes 
(AOPs, which generally involve in-situ production of reactive hydroxyl radicals in the presence of 
primary oxidant and/or energy source or catalysts), and nanofiltration or reverse osmosis can be used 
as an additional treatment for non-potable or potable reuse. Ozone (O3) is a disinfectant that is 
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becoming increasingly popular in water reuse treatment trains. Ozone is a strong oxidizing agent that 
can fragment contaminants and other organics, thus making these contaminants more amenable to 
biodegradation. In the case of antibiotic resistance, ozonation and other advanced oxidation processes 
are promising because they can move past pathogen destruction and actually destroy DNA and 
potentially block the ability of downstream bacteria to acquire antibiotic resistance via transformation 
[55]. However, as is the case for the other disinfection processes that are cited here, studies focused 
on effects of ozone are not fully conclusive and ultimate use of ozonation would be very costly. 
Lüddeke et al. [118] studied the removal of total bacteria and ARB in pilot-scale advanced wastewater 
treatment by ozone in combination with different filtering techniques (i.e., sand filtration and/or 
granulated activated carbon). Ozone was able to improve bacterial removal by about 1 LRV with a 
contact time of 20 min in the presence of 0.73 mg O3/mg dissolved organic carbon. However, the 
study shows that the total level of resistant E. coli and Staphylococcus spp. isolates increased. 
According to Sigmon et al. [119], ozone is able to remove around 2 LRV of E. coli with a CT of 0.65 
mg·min/L at pH 7.6, a temperature of 16 °C and a total organic carbon (TOC) concentration of 17.1 
mg/L. This reported disinfection strategy achieved approximately the same CT value as that in the 
study of Luddeke et al. [118]. However, pH and temperature of the experiment in that study was not 
measured. These findings demonstrate that environmental or operating conditions can have a 
significant influence on the final LRV achieved. 
On the other hand, combining chlorine (i.e., an oxidant) with UV (i.e., energy source) was shown 
to achieve higher log reduction for ARGs like sul1, tet(X), tet(G), and MGEs intI1 than using either 
disinfection strategy alone [120]. The maximum reported LRV for tetX was approximately 2.2-log 
with 249.5 mJ/cm2 of UV irradiation in combination with 30 mg/L chlorine. This is in contrast to 
approximately 0.6 LRV from the same UV fluence alone and 1.5 LRV from the same concentration of 
chlorine [120]. It is important to note that the amount of UV irradiation and chlorine to be added to 
the wastewater effluent to achieve this reported LRV is exceedingly high and may be costly for long-
term operations. Another study demonstrated that the combination of UV and H2O2 was able to 
reduce the UV fluence from ca. 65 mJ/cm2 to 40 mJ/cm2 for the same LRV of 3 when extracellular 
ampicillin resistance genes were suspended in phosphate saline buffer. However, when the same 
extracellular ampicillin resistance genes were suspended in wastewater effluent, the combination of 
H2O2 and UV result in neither a significant reduction in the UV fluence that is required to achieve the 
same log reduction, nor improvement in overall log reduction of ARGs [121]. These findings 
demonstrate that while AOP can potentially be useful for inactivating ARGs in wastewater matrices, 
the additional costs associated with using an oxidant in tandem with an energy source may not be 
entirely justified.  
Among all of the available treatments that are commonly applied for water reuse, membrane 
treatments are most likely to be effective. Membrane treatment options ranked from the loosest to 
tightest size removal criteria include: microfiltration (MF), ultrafiltration (UF), nanofiltration (NF) 
and reverse osmosis (RO). MF, UF, and NF would suffice if the treated water is intended for non-
potable reuse purpose while an additional RO step is typically used to achieve a final product suitable 
for potable reuse. MF, UF, and NF membranes are commonly applied in tandem with activated 
sludge treatment as an alternative to a settling tank. LRV of bacterial contaminants reported by MBRs 
are collated in a recent review paper [41]. When comparing the reported influent and effluent 
abundances of bacteria, it is apparent that membranes are a well-established barrier to remove 
bacteria at high LRV, but whether these reported LRVs can be translated to ARB would remain 
unknown. This is because antimicrobial molecules are known for inducing alterations in the bacterial 
envelope and in its mechanical properties [122,123]. Variances in cell rigidity may apply to ARB, 
which can consequently trigger passage of ARB through membranes at a different rate than non-
antibiotic bacterial cells. Besides size exclusion, other factors, such as adsorption onto the membrane, 
can also aid in removing ARB and ARGs from wastewater. In fact, adsorption may play a more 
important role in removing ARGs than size exclusion alone. This is because studies have indicated 
that naked DNA containing ARGs could be effectively removed by fouled UF [124] and MF 
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membranes [125]. These are promising results since UF- and MF-based MBRs are typically operated 
at lower energy requirement than NF or RO, and thus incur lower costs. 
Membrane separation processes can also be applied together with anaerobic fermentation 
process to further lower energy and costs that are required to operate MBRs. Life cycle analysis 
revealed that anaerobic membrane bioreactors (anMBRs) hold promise in providing a sustainable 
way to treat municipal wastewater due to its capacity to produce methane that can be harvested to 
become an energy source and its low solid waste production rate [126]. This is in contrast to the 
aerobic MBRs, which require energy for aeration and generate large volumes of antibiotics-laden 
sludge requiring disposal. Recent studies also suggest that anMBR may provide treated effluent that 
is safer than that produced by aerobic MBR. This is exemplified from the higher removal rates of the 
majority of the detected bacterial contaminants than aerobic MBR [127], and a lower occurrence of 
ARGs in anMBR than aerobic MBR when exposed to similar concentrations of antibiotics [128]. 
However, anaerobic processes alone do not remove ammonia and phosphorus from municipal 
wastewaters, and can result in environmental concerns (e.g. eutrophication in surface waters) or 
breaches in the potable water quality when used upstream of a water reclamation plant. Hence, 
combining aerobic and anaerobic processes by using sequential redox conditions to select/remove 
different types of ARB and ARGs with lower energy use and nutrient removal may be the ultimate 
solution [129].  
Overall, it is reasonable to conclude that the advanced treatment processes applied in potable 
reuse treatment trains are likely to reduce ARB and ARGs to levels that are negligible compared to 
background concentrations [130].  
6. Concluding Statement 
There is an urgent need to more comprehensively evaluate resulting environmental and public 
health concerns that may arise from water reuse. A growing volume of research has brought to light 
the ubiquitous presence of ARB and ARGs in wastewater and has demonstrated that conventional 
WWTPs do not fully remove these contaminants from the final treated effluent. Despite mounting 
scientific evidence, existing regulations and policies have yet to determine permissible levels of ARB 
and ARGs in final treated water. A “One Water” framework in which multiple barriers are emplaced 
to protect public health is advisable. Addressing various knowledge gaps that were highlighted in 
this perspectives paper, including the need to identify suitable targets and inadequate risk 
assessment models, can help to facilitate effective recycled water management to ensure utmost 
protection of public health. In the meantime, it is important to consider both source prevention and 
treatment technologies to minimize the potential detrimental impact arising from ARB and ARGs in 
wastewaters. 
Acknowledgments: This paper was conceived at the KAUST Research Conference “Changing paradigms of 
wastewater treatment—from waste to resource” held on 27–29 March 2017. The conference was sponsored by 
KAUST Office of Sponsored Research (OSR) and was organized by Water Desalination and Reuse Center 
(WDRC). 
Author Contributions: Pei-Ying Hong and C.M. M. conceived the outline of this paper; Célia M. Manaia and 
Pei-Ying Hong contributed to Section 2; Amy Pruden, Célia M. Manaia and Pei-Ying Hong contributed to Section 
3; Timothy R. Julian, Sunny C. Jiang and Kara L. Nelson contributed to Section 4; Amy Pruden, Pei-Ying Hong, 
Kara L. Nelson, Marie-Laure Pype and David Graham contributed to Section 5; Pei-Ying Hong collated and 
synthesized the contributions from all authors. 
Conflicts of Interest: The authors declare no conflict of interest. 
References and Notes 
1. Jimenez, B.; Asano, T. Water Reuse: An International Survey of Current Practice, Issues and Needs (Scientific and 
Technical Report); IWA Publishing: London, UK, 2008. 
2. AQUASTAT. Fao’s Global Water Information System. Available online: http://www.fao.org/nr/water/ 
aquastat/infographics/Infographics_all_eng.pdf (accessed on 5 October 2017).  
Water 2018, 10, 244 16 of 21 
 
3. Thebo, A.L.; Drechsel, P.; Lambin, E.F. Global assessment of urban and peri-urban agriculture: Irrigated 
and rainfed croplands. Environ. Res. Lett. 2014, 9, 114002. 
4. Pescod, M.B. Wastewater Treatment and Use in Agriculture. Fao Irrigation and Drainage Paper 47; FAO of the 
United Nations: Rome, Italy, 1992; p. 125. 
5. Thebo, A.L.; Drechsel, P.; Lambin, E.F.; Nelson, K.L. A global, spatially-explicit assessment of irrigated 
croplands influenced by urban wastewater flows. Environ. Res. Lett. 2017, 12, 074008. 
6. Nuclear Regulatory Commission (NRC). Water Reuse: Potential for Expanding the Nation’s Water Supply 
through Reuse of Municipal Wastewater. Available online: https://www.nap.edu/catalog/13303/water-
reuse-potential-for-expanding-the-nations-water-supply-through (accessed on 9 November 2017).  
7. International Water Association (IWA). History of Activated Sludge. Available online: 
http://www.iwa100as.org/history.php (accessed on 5 October 2017).  
8. Luo, Y.; Guo, W.; Ngo, H.H.; Nghiem, L.D.; Hai, F.I.; Zhang, J.; Liang, S.; Wang, X.C. A review on the 
occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater 
treatment. Sci. Total Environ. 2014, 473-474, 619–641. 
9. Barbosa, M.O.; Moreira, N.F.; Ribeiro, A.R.; Pereira, M.F.; Silva, A.M. Occurrence and removal of organic 
micropollutants: An overview of the watch list of eu decision 2015/495. Water Res. 2016, 94, 257–279. 
10. World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance; WHO: Geneva, 
Switzerland, 2014. 
11. Berendonk, T.U.; Manaia, C.M.; Merlin, C.; Fatta-Kassinos, D.; Cytryn, E.; Walsh, F.; Burgmann, H.; Sorum, 
H.; Norstrom, M.; Pons, M.N.; et al. Tackling antibiotic resistance: The environmental framework. Nat. Rev. 
Microbiol. 2015, 13, 310–317. 
12. Bush, K.; Courvalin, P.; Dantas, G.; Davies, J.; Eisenstein, B.; Huovinen, P.; Jacoby, G.A.; Kishony, R.; 
Kreiswirth, B.N.; Kutter, E.; et al. Tackling antibiotic resistance. Nat. Rev. Microbiol. 2011, 9, 894–896. 
13. Clatworthy, A.E.; Pierson, E.; Hung, D.T. Targeting virulence: A new paradigm for antimicrobial therapy. 
Nat. Chem. Biol. 2007, 3, 541–548. 
14. Kieffer, N.; Poirel, L.; Bessa, L.J.; Barbosa-Vasconcelos, A.; da Costa, P.M.; Nordmann, P. Vim-1, vim-34, 
and imp-8 carbapenemase-producing escherichia coli strains recovered from a portuguese river. 
Antimicrob. Agents Chemother. 2016, 60, 2585–2586. 
15. Mahon, B.M.; Brehony, C.; McGrath, E.; Killeen, J.; Cormican, M.; Hickey, P.; Keane, S.; Hanahoe, B.; Dolan, 
A.; Morris, D. Indistinguishable ndm-producing escherichia coli isolated from recreational waters, sewage, 
and a clinical specimen in ireland, 2016 to 2017. Eurosurveillance 2017, 22, 30513. 
16. Ashbolt, N.J.; Amezquita, A.; Backhaus, T.; Borriello, P.; Brandt, K.K.; Collignon, P.; Coors, A.; Finley, R.; 
Gaze, W.H.; Heberer, T.; et al. Human health risk assessment (HHRA) for environmental development and 
transfer of antibiotic resistance. Environ. Health Perspect. 2013, 121, 993–1001. 
17. Manaia, C.M. Assessing the risk of antibiotic resistance transmission from the environment to humans: 
Non-direct proportionality between abundance and risk. Trends Microbiol. 2017, 25, 173–181. 
18. Huang, X.; Zhao, Z.; Hernandez, D.; Jiang, S. Near real-time flow cytometry monitoring of bacterial and 
viral removal efficiencies during water reclamation processes. Water 2016, 8, 464. 
19. Kokjohn, T.A.; Sayler, G.S. Attachment and replication of pseudomonas aeruginosa bacteriophages under 
conditions simulating aquatic environments. J. Gen. Microbiol. 1991, 137, 661–666. 
20. Muniesa, M.; Jofre, J. Factors influencing the replication of somatic coliphages in the water environment. 
Antonie Van Leeuwenhoek 2004, 86, 65–76. 
21. Fuhrman, J.A. Marine viruses and their biogeochemical and ecological effects. Nature 1999, 399, 541–548. 
22. Miller, R.V.; Ripp, S.; Replicon, J.; Ogunseitan, O.A.; Kokjohn, T.A. Virus-mediated gene transfer in 
freshwater environments. In Gene Transfers and Environment: Proceedings of the Third European Meeting on 
Bacterial Genetics and Ecology (bageco-3), Villefranche-sur-mer, France, 20–22 November 1991; Gauthier, M.J., 
Ed.; Springer: Berlin/Heidelberg, Germany, 1992; pp. 51–62. 
23. European Economic Community (EEC). Concerning Urban Wastewater Treatment, Council Directive 
91/271/EEC, 1991. 
24. Becerra-Castro, C.; Lopes, A.R.; Vaz-Moreira, I.; Silva, E.F.; Manaia, C.M.; Nunes, O.C. Wastewater reuse 
in irrigation: A microbiological perspective on implications in soil fertility and human and environmental 
health. Environ. Int. 2015, 75, 117–135. 
25. European Economic Community (EEC). Amending council directive 91/271/EEC, Commission directive 
98/15/EC, 1998. 
Water 2018, 10, 244 17 of 21 
 
26. European Economic Community (EEC). Establishing a framework for community action in the field of 
water policy–EU water framework, Directive (2000/60/EC), 2000. 
27. European Economic Community (EEC). Amending directives 2000/60/EC and 2008/105/EC as regards 
priority substances in the field of water policy, Directive 2013/39/EU, 2013. 
28. European Economic Community (EEC). On the quality of water intended for human consumption, Council 
directive 98/83/EC, 1998. 
29. World Health Organization (WHO). Quantitative Microbial Risk Assessment: Application for Water Safety 
Management; WHO: Geneva, Switzerland, 2016. 
30. World Health Organization (WHO). Guidelines for Drinking Water Quality: Fourth Edition Incorporating 
the First Addendum. Available online: http://www.who.int/water_sanitation_health/publications/ 
drinking-water-quality-guidelines-4-including-1st-addendum/en/ (accessed on 17 December 2017).  
31. World Health Organization (WHO). Who Guidelines for the Safe Use of Wastewater, Excreta and Greywater; 
WHO: Geneva, Switzerland, 2006. 
32. Manaia, C.M.; Macedo, G.; Fatta-Kassinos, D.; Nunes, O.C. Antibiotic resistance in urban aquatic 
environments: Can it be controlled? Appl. Microbiol. Biotechnol. 2016, 100, 1543–1557. 
33. Di Cesare, A.; Fontaneto, D.; Doppelbauer, J.; Corno, G. Fitness and recovery of bacterial communities and 
antibiotic resistance genes in urban wastewaters exposed to classical disinfection treatments. Environ. Sci. 
Technol. 2016, 50, 10153–10161. 
34. McKinney, C.W.; Pruden, A. Ultraviolet disinfection of antibiotic resistant bacteria and their antibiotic 
resistance genes in water and wastewater. Environ. Sci. Technol. 2012, 46, 13393–13400. 
35. Washington, J.A. Principles of diagnosis. In Medical Microbiology, 4th ed.; Baron, S., Ed.; University of Texas 
Medical Branch at Galveston: Galveston, TX, USA, 1996. 
36. Garner, E.; Wallace, J.S.; Argoty, G.A.; Wilkinson, C.; Fahrenfeld, N.; Heath, L.S.; Zhang, L.; Arabi, M.; Aga, 
D.S.; Pruden, A. Metagenomic profiling of historic colorado front range flood impact on distribution of 
riverine antibiotic resistance genes. Sci. Rep. 2016, 6, 38432. 
37. Gatica, J.; Tripathi, V.; Green, S.; Manaia, C.M.; Berendonk, T.; Cacace, D.; Merlin, C.; Kreuzinger, N.; 
Schwartz, T.; Fatta-Kassinos, D.; et al. High throughput analysis of integron gene cassettes in wastewater 
environments. Environ. Sci. Technol. 2016, 50, 11825–11836. 
38. Balcazar, J.L. Bacteriophages as vehicles for antibiotic resistance genes in the environment. PLoS Pathog. 
2014, 10, e1004219. 
39. Colomer-Lluch, M.; Jofre, J.; Muniesa, M. Antibiotic resistance genes in the bacteriophage DNA fraction of 
environmental samples. PLoS ONE 2011, 6, e17549. 
40. Hong, P.Y.; Al-Jassim, N.; Ansari, M.I.; Mackie, R.I. Environmental and public health implications of water 
reuse: Antibiotics, antibiotic resistant bacteria, and antibiotic resistance genes. Antibiotics 2013, 2, 367–399. 
41. Harb, M.; Hong, P.-Y. Anaerobic membrane bioreactor effluent reuse: A review of microbial safety 
concerns. Fermentation 2017, 3, 39. 
42. Garmendia, L.; Hernandez, A.; Sanchez, M.B.; Martinez, J.L. Metagenomics and antibiotics. Clin. Microbiol. 
Infect. 2012, 18 Suppl 4, 27–31. 
43. Martinez, J.L.; Coque, T.M.; Baquero, F. Prioritizing risks of antibiotic resistance genes in all metagenomes. 
Nat. Rev. Microbiol. 2015, 13, 396. 
44. Martinez, J.L.; Coque, T.M.; Baquero, F. What is a resistance gene? Ranking risk in resistomes. Nat. Rev. 
Microbiol. 2015, 13, 116–123. 
45. Wang, F.H.; Qiao, M.; Su, J.Q.; Chen, Z.; Zhou, X.; Zhu, Y.G. High throughput profiling of antibiotic 
resistance genes in urban park soils with reclaimed water irrigation. Environ. Sci. Technol. 2014, 48,  
9079–9085. 
46. Arango-Argoty, G.; Singh, G.; Heath, L.S.; Pruden, A.; Xiao, W.; Zhang, L. Metastorm: A public resource 
for customizable metagenomics annotation. PLoS ONE 2016, 11, e0162442. 
47. Jia, B.; Raphenya, A.R.; Alcock, B.; Waglechner, N.; Guo, P.; Tsang, K.K.; Lago, B.A.; Dave, B.M.; Pereira, 
S.; Sharma, A.N.; et al. Card 2017: Expansion and model-centric curation of the comprehensive antibiotic 
resistance database. Nucleic Acids Res. 2017, 45, D566–D573. 
48. Yang, Y.; Jiang, X.; Chai, B.; Ma, L.; Li, B.; Zhang, A.; Cole, J.R.; Tiedje, J.M.; Zhang, T. Args-oap: Online 
analysis pipeline for antibiotic resistance genes detection from metagenomic data using an integrated 
structured arg-database. Bioinformatics 2016, 32, 2346–2351. 
Water 2018, 10, 244 18 of 21 
 
49. Bhullar, K.; Waglechner, N.; Pawlowski, A.; Koteva, K.; Banks, E.D.; Johnston, M.D.; Barton, H.A.; Wright, 
G.D. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS ONE 2012, 7, e34953. 
50. Brown, M.G.; Balkwill, D.L. Antibiotic resistance in bacteria isolated from the deep terrestrial subsurface. 
Microb. Ecol. 2009, 57, 484–493. 
51. Gillings, M.; Boucher, Y.; Labbate, M.; Holmes, A.; Krishnan, S.; Holley, M.; Stokes, H.W. The evolution of 
class 1 integrons and the rise of antibiotic resistance. J. Bacteriol. 2008, 190, 5095–5100. 
52. Gillings, M.R.; Gaze, W.H.; Pruden, A.; Smalla, K.; Tiedje, J.M.; Zhu, Y.G. Using the class 1  
integron-integrase gene as a proxy for anthropogenic pollution. ISME J. 2015, 9, 1269–1279. 
53. World Health Organization (WHO). Who Publishes List of Bacteria for Which New Antibiotics Are 
Urgently Needed. Available online: http://www.who.int/mediacentre/news/releases/2017/bacteria-
antibiotics-needed/en/ (accessed on 5 October 2017).  
54. Haas, C.N.; Rose, J.B.; Gerba, C.P. Quantitative Microbial Risk Assessment, 2nd ed.; World Health 
Organization (WHO): Geneva, Switzerland, 2014; p. 440. 
55. Pruden, A. Balancing water sustainability and public health goals in the face of growing concerns about 
antibiotic resistance. Environ. Sci. Technol. 2014, 48, 5–14. 
56. ECDC/EMEA. The Bacterial Challenge: Time to React; ECDC/EMEA: Solna, Sweden, 2009; ISBN 
9789291931934. 
57. Al-Jassim, N.; Mantilla-Calderon, D.; Wang, T.; Hong, P.Y. Inactivation and gene expression of a virulent 
wastewater escherichia coli strain and the nonvirulent commensal escherichia coli dsm1103 strain upon 
solar irradiation. Environ. Sci. Technol. 2017, 51, 3649–3659. 
58. Brunkard, J.M.; Ailes, E.; Roberts, V.A.; Hill, V.; Hilborn, E.D.; Craun, G.F.; Rajasingham, A.; Kahler, A.; 
Garrison, L.; Hicks, L.; et al. Surveillance for waterborne disease outbreaks associated with drinking 
water―united states, 2007–2008. MMWR Surveill. Summ. 2011, 60, 38–68. 
59. Parsley, L.C.; Consuegra, E.J.; Kakirde, K.S.; Land, A.M.; Harper, W.F., Jr.; Liles, M.R. Identification of 
diverse antimicrobial resistance determinants carried on bacterial, plasmid, or viral metagenomes from an 
activated sludge microbial assemblage. Appl. Environ. Microbiol. 2010, 76, 3753–3757. 
60. Rizzo, L.; Manaia, C.; Merlin, C.; Schwartz, T.; Dagot, C.; Ploy, M.C.; Michael, I.; Fatta-Kassinos, D. Urban 
wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the 
environment: A review. Sci. Total Environ. 2013, 447, 345–360. 
61. Imamovic, L.; Jofre, J.; Schmidt, H.; Serra-Moreno, R.; Muniesa, M. Phage-mediated shiga toxin 2 gene 
transfer in food and water. Appl. Environ. Microbiol. 2009, 75, 1764–1768. 
62. Jiang, S.C.; Paul, J.H. Gene transfer by transduction in the marine environment. Appl. Environ. Microbiol. 
1998, 64, 2780–2787. 
63. Ogunseitan, O.A. Genetic transduction in freshwater ecosystems. Freshwater Biol. 2008, 53, 1228–1239. 
64. Brown-Jaque, M.; Calero-Caceres, W.; Muniesa, M. Transfer of antibiotic-resistance genes via phage-related 
mobile elements. Plasmid 2015, 79, 1–7. 
65. Penades, J.R.; Chen, J.; Quiles-Puchalt, N.; Carpena, N.; Novick, R.P. Bacteriophage-mediated spread of 
bacterial virulence genes. Curr. Opin. Microbiol. 2015, 23, 171–178. 
66. Davison, J. Genetic exchange between bacteria in the environment. Plasmid 1999, 91, 73–91. 
67. Keen, E.C.; Bliskovsky, V.V.; Malagon, F.; Baker, J.D.; Prince, J.S.; Klaus, J.S.; Adhya, S.L. Novel 
“superspreader” bacteriophages promote horizontal gene transfer by transformation. MBio 2017, 8,  
e02115–e02116. 
68. Al-Jassim, N.; Ansari, M.I.; Harb, M.; Hong, P.Y. Removal of bacterial contaminants and antibiotic 
resistance genes by conventional wastewater treatment processes in saudi arabia: Is the treated wastewater 
safe to reuse for agricultural irrigation? Water Res. 2015, 73, 277–290. 
69. Jumat, M.R.; Hasan, N.A.; Subramanian, P.; Heberling, C.; Colwell, R.R.; Hong, P.Y. Membrane bioreactor-
based wastewater treatment plant in saudi arabia: Reduction of viral diversity, load, and infectious 
capacity. Water 2017, 9, 534. 
70. Melnyk, A.H.; Wong, A.; Kassen, R. The fitness costs of antibiotic resistance mutations. Evol. Appl. 2015, 8, 
273–283. 
71. Vogwill, T.; MacLean, R.C. The genetic basis of the fitness costs of antimicrobial resistance: A meta-analysis 
approach. Evol. Appl. 2015, 8, 284–295. 
72. Mantilla-Calderon, D.; Hong, P.Y. Fate and persistence of a pathogenic ndm-1-positive escherichia coli 
strain in anaerobic and aerobic sludge microcosms. Appl. Environ. Microbiol. 2017, 83, e00640-17.  
Water 2018, 10, 244 19 of 21 
 
73. Roux, D.; Danilchanka, O.; Guillard, T.; Cattoir, V.; Aschard, H.; Fu, Y.; Angoulvant, F.; Messika, J.; Ricard, 
J.D.; Mekalanos, J.J.; et al. Fitness cost of antibiotic susceptibility during bacterial infection. Sci. Transl. Med. 
2015, 7, 297ra114. 
74. Donskey, C.J. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative 
bacilli. Clin. Infect Dis. 2006, 43 (Suppl. 2), S62–S69. 
75. Nordgard, L.; Brusetti, L.; Raddadi, N.; Traavik, T.; Averhoff, B.; Nielsen, K.M. An investigation of 
horizontal transfer of feed introduced DNA to the aerobic microbiota of the gastrointestinal tract of rats. 
BMC Res. Notes 2012, 5, 170. 
76. Nordgard, L.; Nguyen, T.; Midtvedt, T.; Benno, Y.; Traavik, T.; Nielsen, K.M. Lack of detectable DNA 
uptake by bacterial gut isolates grown in vitro and by acinetobacter baylyi colonizing rodents in vivo. 
Environ. Biosafety Res. 2007, 6, 149–160. 
77. Rizzi, A.; Brusetti, L.; Arioli, S.; Nielsen, K.M.; Tamagnini, I.; Tamburini, A.; Sorlini, C.; Daffonchio, D. 
Detection of feed-derived maize DNA in goat milk and evaluation of the potential of horizontal transfer to 
bacteria. Eur. Food Res. Technol. 2008, 227, 1699–1709. 
78. Wilcks, A.; Jacobsen, B.B. Lack of detectable DNA uptake by transformation of selected recipients in mono-
associated rats. BMC Res. Notes 2010, 3, 49. 
79. Enault, F.; Briet, A.; Bouteille, L.; Roux, S.; Sullivan, M.B.; Petit, M.A. Phages rarely encode antibiotic 
resistance genes: A cautionary tale for virome analyses. ISME J. 2017, 11, 237–247. 
80. Lim, K.Y.; Hamilton, A.J.; Jiang, S.C. Assessment of public health risk associated with viral contamination 
in harvested urban stormwater for domestic applications. Sci. Total Environ. 2015, 523, 95–108. 
81. CDC. One Health. Available online: https://www.cdc.gov/onehealth/index.html (accessed on 9 November 
2017).  
82. USWaterAlliance. One Water Roadmap: The Sustainable Management of Life’s Most Essential Resource. 
Available online: http://uswateralliance.org//one-water/roadmap (accessed on 9 November 2017).  
83. Negreanu, Y.; Pasternak, Z.; Jurkevitch, E.; Cytryn, E. Impact of treated wastewater irrigation on antibiotic 
resistance in agricultural soils. Environ. Sci. Technol. 2012, 46, 4800–4808. 
84. Fahrenfeld, N.; Ma, Y.; O’Brien, M.; Pruden, A. Reclaimed water as a reservoir of antibiotic resistance genes: 
Distribution system and irrigation implications. Front. Microbiol. 2013, 4, 130. 
85. Han, X.M.; Hu, H.W.; Shi, X.Z.; Wang, J.T.; Han, L.L.; Chen, D.; He, J.Z. Impacts of reclaimed water 
irrigation on soil antibiotic resistome in urban parks of victoria, australia. Environ. Pollut. 2016, 211, 48–57. 
86. Bengtsson-Palme, J.; Larsson, D.G.J. Concentrations of antibiotics predicted to select for resistant bacteria: 
Proposed limits for environmental regulation. Environ. Int. 2016, 86, 140–149. 
87. Czekalski, N.; Berthold, T.; Caucci, S.; Egli, A.; Burgmann, H. Increased levels of multiresistant bacteria and 
resistance genes after wastewater treatment and their dissemination into lake geneva, switzerland. Front. 
Microbiol. 2012, 3, 106. 
88. Iweriebor, B.C.; Gaqavu, S.; Obi, L.C.; Nwodo, U.U.; Okoh, A.I. Antibiotic susceptibilities of enterococcus 
species isolated from hospital and domestic wastewater effluents in alice, eastern cape province of South 
Africa. Int. J. Environ. Res. Public Health 2015, 12, 4231–4246. 
89. Kotlarska, E.; Luczkiewicz, A.; Pisowacka, M.; Burzynski, A. Antibiotic resistance and prevalence of class 
1 and 2 integrons in escherichia coli isolated from two wastewater treatment plants, and their receiving 
waters (gulf of gdansk, baltic sea, Poland). Environ. Sci. Pollut. Res. Int. 2015, 22, 2018–2030. 
90. Narciso-da-Rocha, C.; Varela, A.R.; Schwartz, T.; Nunes, O.C.; Manaia, C.M. Blatem and vana as indicator 
genes of antibiotic resistance contamination in a hospital–urban wastewater treatment plant system. J. Glob. 
Antimicrob. Resist. 2014, 2, 309–315. 
91. Timraz, K.; Xiong, Y.H.; Al Qarni, H.; Hong, P.Y. Removal of bacterial cells, antibiotic resistance genes and 
integrase genes by on-site hospital wastewater treatment plants: Surveillance of treated hospital effluent 
quality. Environ. Sci.-Wat. Res. 2017, 3, 293–303. 
92. Bengtsson-Palme, J.; Boulund, F.; Fick, J.; Kristiansson, E.; Larsson, D.G. Shotgun metagenomics reveals a 
wide array of antibiotic resistance genes and mobile elements in a polluted lake in India. Front. Microbiol. 
2014, 5, 648. 
93. Schwartz, T. Strategies to assess and minimize the biological risk of antibiotic resistance in the environment. 
In Antimicrobial Resistance in the Environment; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2011; pp.  
251–264. 
Water 2018, 10, 244 20 of 21 
 
94. Garner, E.; Zhu, N.; Strom, L.; Edwards, M.; Pruden, A. A human exposome framework for guiding risk 
management and holistic assessment of recycled water quality. Environ. Sci. Water Res. Technol. 2016, 2,  
580–598. 
95. Ahammad, Z.S.; Sreekrishnan, T.R.; Hands, C.L.; Knapp, C.W.; Graham, D.W. Increased waterborne 
blandm-1 resistance gene abundances associated with seasonal human pilgrimages to the upper ganges 
river. Environ. Sci. Technol. 2014, 48, 3014–3020. 
96. Mantilla-Calderon, D.; Jumat, M.R.; Wang, T.; Ganesan, P.; Al-Jassim, N.; Hong, P.Y. Isolation and 
characterization of ndm-positive escherichia coli from municipal wastewater in jeddah, saudi arabia. 
Antimicrob. Agents Chemother. 2016, 60, 5223–5231. 
97. Novo, A.; Manaia, C.M. Factors influencing antibiotic resistance burden in municipal wastewater treatment 
plants. Appl. Microbiol. Biotechnol. 2010, 87, 1157–1166. 
98. Li, D.; Zeng, S.; He, M.; Gu, A.Z. Water disinfection byproducts induce antibiotic resistance-role of 
environmental pollutants in resistance phenomena. Environ. Sci. Technol. 2016, 50, 3193–3201. 
99. Zhang, Y.; Gu, A.Z.; He, M.; Li, D.; Chen, J. Subinhibitory concentrations of disinfectants promote the 
horizontal transfer of multidrug resistance genes within and across genera. Environ. Sci. Technol. 2017, 51, 
570–580. 
100. Pruden, A.; Larsson, D.G.; Amezquita, A.; Collignon, P.; Brandt, K.K.; Graham, D.W.; Lazorchak, J.M.; 
Suzuki, S.; Silley, P.; Snape, J.R.; et al. Management options for reducing the release of antibiotics and 
antibiotic resistance genes to the environment. Environ. Health Perspect. 2013, 121, 878–885. 
101. Mao, D.Q.; Yu, S.; Rysz, M.; Luo, Y.; Yang, F.X.; Li, F.X.; Hou, J.; Mu, Q.H.; Alvarez, P.J.J. Prevalence and 
proliferation of antibiotic resistance genes in two municipal wastewater treatment plants. Water Res. 2015, 
85, 458–466. 
102. Yuan, Q.B.; Guo, M.T.; Wei, W.J.; Yang, J. Reductions of bacterial antibiotic resistance through five 
biological treatment processes treated municipal wastewater. Environ. Sci. Pollut. Res. 2016, 23, 19495–
19503. 
103. Marcinek, H.; Wirth, R.; Muscholl-Silberhorn, A.; Gauer, M. Enterococcus faecalis gene transfer under 
natural conditions in municipal sewage water treatment plants. Appl. Environ. Microbiol. 1998, 64, 626–632. 
104. Ferreira da Silva, M.; Tiago, I.; Verissimo, A.; Boaventura, R.A.; Nunes, O.C.; Manaia, C.M. Antibiotic 
resistance of enterococci and related bacteria in an urban wastewater treatment plant. FEMS Microbiol. Ecol. 
2006, 55, 322–329. 
105. Auerbach, E.A.; Seyfried, E.E.; McMahon, K.D. Tetracycline resistance genes in activated sludge 
wastewater treatment plants. Water Res. 2007, 41, 1143–1151. 
106. Kim, S.; Jensen, J.N.; Aga, D.S.; Weber, A.S. Tetracycline as a selector for resistant bacteria in activated 
sludge. Chemosphere 2007, 66, 1643–1651. 
107. Łuczkiewicz, A.; Jankowska, K.; Fudala-Książek, S.; Olańczuk-Neyman, K. Antimicrobial resistance of fecal 
indicators in municipal wastewater treatment plant. Water Res. 2010, 44, 5089–5097. 
108. Neyestani, M.; Dickenson, E.; McLain, J.; Robleto, E.; Rock, C.; Gerrity, D. Impacts of solids retention time 
on trace organic compound attenuation and bacterial resistance to trimethoprim and sulfamethoxazole. 
Chemosphere 2017, 182, 149-158. 
109. Munck, C.; Albertsen, M.; Telke, A.; Ellabaan, M.; Nielsen, P.H.; Sommer, M.O. Limited dissemination of 
the wastewater treatment plant core resistome. Nat. Commun. 2015, 6, 8452. 
110. WaterSecure. Chlorine disinfection. In WaterVal Validation Protocol; Australian WaterSecure Innovations 
Ltd.: Brisbane, Australia, 2017. 
111. USEPA. Disinfection Profiling and Benchmarking Guidance Manual; Agency, U.S.E.P., Ed.; U.S.EPA: 
Washington, DC, USA, 1999. 
112. Guo, M.-T.; Yuan, Q.-B.; Yang, J. Distinguishing effects of ultraviolet exposure and chlorination on the 
horizontal transfer of antibiotic resistance genes in municipal wastewater. Environ. Sci. Technol. 2015, 49, 
5771–5778. 
113. Munir, M.; Wong, K.; Xagoraraki, I. Release of antibiotic resistant bacteria and genes in the effluent and 
biosolids of five wastewater utilities in michigan. Water Res. 2011, 45, 681–693. 
114. Murray, G.E.; Tobin, R.S.; Junkins, B.; Kushner, D.J. Effect of chlorination on antibiotic resistance profiles 
of sewage related bacteria. Appl. Environ. Microbiol. 1984, 48, 73–77. 
Water 2018, 10, 244 21 of 21 
 
115. Oncu, N.B.; Menceloglu, Y.Z.; Balcioglu, I.A. Comparison of the effectiveness of chlorine, ozone, and 
photocatalytic disinfection in reducing the risk of antibiotic resistance pollution. J. Adv. Oxid. Technol. 2011, 
14, 196–203. 
116. Suquet, C.; Warren, J.J.; Seth, N.; Hurst, J.K. Comparative study of hocl-inflicted damage to bacterial DNA 
ex vivo and within cells. Arch. Biochem. Biophys. 2010, 493, 135–142. 
117. USEPA. Ultraviolet disinfection guidance manual for the final long term 2 enhanced surface water 
treatment rule. In EPA 815-R-06-007; United States Environmental Protection Agency: Washington, DC, 
USA, 2006; p. 436. 
118. Luddeke, F.; Hess, S.; Gallert, C.; Winter, J.; Gude, H.; Loffler, H. Removal of total and antibiotic resistant 
bacteria in advanced wastewater treatment by ozonation in combination with different filtering techniques. 
Water Res. 2015, 69, 243–251. 
119. Sigmon, C.; Shin, G.A.; Mieog, J.; Linden, K.G. Establishing surrogate-virus relationships for ozone 
disinfection of wastewater. Environ. Eng. Sci. 2015, 32, 451–460. 
120. Zhang, Y.; Zhuang, Y.; Geng, J.; Ren, H.; Zhang, Y.; Ding, L.; Xu, K. Inactivation of antibiotic resistance 
genes in municipal wastewater effluent by chlorination and sequential uv/chlorination disinfection. Sci. 
Total Environ. 2015, 512–513, 125–132. 
121. Yoon, Y.; Chung, H.J.; Wen Di, D.Y.; Dodd, M.C.; Hur, H.G.; Lee, Y. Inactivation efficiency of plasmid-
encoded antibiotic resistance genes during water treatment with chlorine, uv, and uv/h2o2. Water Res. 2017, 
123, 783–793. 
122. Formosa, C.; Grare, M.; Duval, R.E.; Dague, E. Nanoscale effects of antibiotics on p. Aeruginosa. Nanomed. 
Nanotechnol. Biol. Med. 2012, 8, 12–16. 
123. Formosa, C.; Grare, M.; Jauvert, E.; Coutable, A.; Regnouf-de-Vains, J.B.; Mourer, M.; Duval, R.E.; Dague, 
E. Nanoscale analysis of the effects of antibiotics and cx1 on a pseudomonas aeruginosa multidrug-resistant 
strain. Sci. Rep. 2012, 2, 575. 
124. Breazeal, M.V.; Novak, J.T.; Vikesland, P.J.; Pruden, A. Effect of wastewater colloids on membrane removal 
of antibiotic resistance genes. Water Res. 2013, 47, 130–140. 
125. Cheng, H.; Hong, P.Y. Removal of antibiotic-resistant bacteria and antibiotic resistance genes affected by 
varying degrees of fouling on anaerobic microfiltration membranes. Environ. Sci. Technol. 2017, 51,  
12200–12209. 
126. Shoener, B.D.; Zhong, C.; Greiner, A.D.; O. Khunjar, W.; Hong, P.-Y.; Guest, J.S. Design of anaerobic 
membrane bioreactors for the valorization of dilute organic carbon waste streams. Energy Environ. Sci. 2016, 
9, 1102–1112. 
127. Harb, M.; Hong, P.Y. Molecular-based detection of potentially pathogenic bacteria in membrane bioreactor 
(MBR) systems treating municipal wastewater: A case study. Environ. Sci. Pollut. Res. Int. 2017, 24,  
5370–5380. 
128. Harb, M.; Wei, C.H.; Wang, N.; Amy, G.; Hong, P.Y. Organic micropollutants in aerobic and anaerobic 
membrane bioreactors: Changes in microbial communities and gene expression. Bioresour. Technol. 2016, 
218, 882–891. 
129. Christgen, B.; Yang, Y.; Ahammad, S.Z.; Li, B.; Rodriquez, D.C.; Zhang, T.; Graham, D.W. Metagenomics 
shows that low-energy anaerobic-aerobic treatment reactors reduce antibiotic resistance gene levels from 
domestic wastewater. Environ. Sci. Technol. 2015, 49, 2577–2584 
130. Olivieri, A.W.; Crook, J.; Anderson, M.A.; Bull, R.J.; Drewes, J.E.; Haas, C.N.; Jakubowski, W.; McCarty, 
P.L.; Nelson, K.L.; Rose, J.B.; et al. Expert Panel Final Report: Evaluation of the Feasibility of Developing Uniform 
Water Recycling Criteria for Direct Potable Reuse; National Water Research Institute for the State Water 
Resources Control Board: Sacramento, CA, USA, 2016. 
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access 
article distributed under the terms and conditions of the Creative Commons Attribution 
(CC BY) license (http://creativecommons.org/licenses/by/4.0/). 
